INM Stock Summary and Trading Ideas (Inmed Pharmaceuticals - Common Shares | NASDAQ:INM)

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Inmed Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol INM.

As of March 5, 2025, INM stock price climbed to $2.69 with 35,633 million shares trading.

INM has a beta of 3.33, meaning it tends to be more sensitive to market movements. INM has a correlation of 0.08 to the broad based SPY ETF.

INM has a market cap of $3.25 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, INM traded as high as $710.00 and as low as $2.41.

INM has underperformed the market in the last year with a price return of -65.3% while the SPY ETF gained +15.2%. INM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.3% and -15.1%, respectively, while the SPY returned -3.7% and -4.6%, respectively.

INM support price is $2.51 and resistance is $2.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INM shares will trade within this expected range on the day.